VITASPRING BIOMEDICAL CO., LTD. (VSBC) Operating income 2018–2026
VITASPRING BIOMEDICAL CO., LTD. (VSBC) annual operating income history from SEC filings — each fiscal year as reported.
-$385,411FY2026 · since FY2018: -$6,374 → -$385,411
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$385,411 | +43.3% |
| FY2025 | -$679,914 | +39.2% |
| FY2024 | -$1.1M | +73.2% |
| FY2023 | -$4.2M | -470.8% |
| FY2022 | $1.1M | +164.9% |
| FY2021 | $425,382 | +6048.0% |
| FY2020 | $6,919 | +130.9% |
| FY2019 | -$22,396 | -251.4% |
| FY2018 | -$6,374 | — |
Source: SEC XBRL filings · For reference only · Not investment advice